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In malaria, the red blood cell-infectious form of the Plasmodium parasite causes illness and the possible
death of infected hosts. The initial infection in the liver caused by the mosquito-borne sporozoite parasite
stage, however, causes little pathology and no symptoms. Nevertheless, pre-erythrocytic parasite stages
are attracting passionate research efforts not least because they are the most promising targets for malaria
vaccine development. Here, we review how the infectious sporozoite makes its way to the liver and subse-
quently develops within hepatocytes. We discuss the factors, both parasite and host, involved in the interac-
tions that occur during this ‘‘silent’’ phase of infection.Introduction
Malaria is the world’s most deadly parasitic disease and is
caused byPlasmodium parasites belonging to the apicomplexan
phylum. Over 500 million people suffer clinical malaria episodes
annually caused by P. falciparum infection alone resulting in
a conservative estimate of 1 million deaths (Guinovart et al.,
2006; Snow et al., 2005). However, before a victim ever suc-
cumbs to the clinical symptoms of the disease, which present
themselves during the erythrocytic stage of infection, the clini-
cally silent pre-erythrocytic life cycle stages, transmitted by
Anopheles mosquitoes, invade the body and develop in the liver
(Figure 1). The sporozoite transmission stage develops within
a parasite oocyst that is localized under the basal lamina of the
mosquito midgut. Sporozoites are released and invade the mos-
quito salivary glands. Parasite development in the mosquito and
salivary gland infection have been reviewed recently (Matu-
schewski, 2006), and we will here focus on pre-erythrocytic
stage biology in the mammalian host, initiated when sporozoites
are deposited in the skin by an infectious mosquito. The sporo-
zoites enter the blood circulation and are next found in the liver.
Here, sporozoites leave the circulation by passage across the
liver sinusoidal cell layer, traverse through a number of hepato-
cytes, and settle in a final hepatocyte for liver stage develop-
ment. The liver stage grows and undergoes nuclear replication
within a parasitophorous vacuole (PV), culminating in the release
of tens of thousands of merozoites into the circulatory system.
Once free in the blood, merozoites rapidly adhere to and invade
erythrocytes, replicate, and generate further infectious merozo-
ites (reviewed in Cowman and Crabb, 2006). Parasitemia subse-
quently increases, leading to the clinical symptoms of the dis-
ease (reviewed in Greenwood et al., 2005). While in transition
between different tissues and cells in their vector and mamma-
lian host, the single-celled malaria parasites adapt effectively
to their environment. The sporozoite is propelled by a unique ac-
tin-myosin system, which allows extracellular migration, cell tra-
versal, and cell invasion (reviewed in Kappe et al., 2004). Sporo-
zoite interactions with host tissues are mediated by proteins
expressed on the cell surface and by proteins that are released
from a set of secretory organelles called micronemes and rhop-Ctries. Sporozoites undergo extensive developmental regulation
of gene expression that underlies their adaptation to the different
habitats they encounter in the mosquito vector and the mamma-
lian host (Mikolajczak et al., 2008; Siau et al., 2008). During the
past decade, extensive characterization of sporozoites and,
more recently, liver stages, have allowed the identification of
a number of molecular mechanisms used by the parasite during
the pre-erythrocytic life cycle. Reverse genetics tools have en-
abled functional analysis of parasite proteins in vivo. Further-
more, advances in in vivo imaging techniques have provided
a detailed documentation of pre-erythrocytic stage behavior
both in the mosquito and mammalian host (reviewed in Amino
et al., 2005). Most pre-erythrocytic stage research has been con-
ducted using rodent malaria models, but it is assumed that sim-
ilar events govern the initial infection by human malaria parasites.
Thus, it is anticipated that research on rodent malaria will inform
intervention strategy development for malaria control and ulti-
mately eradication. This is best exemplified by efforts to develop
an anti-infection malaria vaccine. In 1967, a seminal paper was
published demonstrating that the inoculation of mice with irradi-
ation-attenuated P. berghei (a rodent malaria parasite) sporozo-
ites induced protection from a subsequent infection with wild-
type sporozoites (Nussenzweig et al., 1967). Thus, the concept
of sterile protection against malaria infection was born. This pa-
per was followed with studies in humans using P. falciparum-
irradiated parasites that gave similar results (Clyde et al., 1973;
Rieckmann et al., 1974). However, in the past, irradiation-atten-
uated sporozoites were never considered a practical vaccine
due to technical issues with ensuring precisely dosed irradiation
and the challenges associated with mass production and preser-
vation of a live vaccine. Consequently, work focused on using
the major sporozoite surface protein, circumsporozoite protein
(CSP), as a recombinant vaccine. Unfortunately, CSP-based
vaccine candidates do not provide sterile protection in malaria-
endemic areas (Alonso et al., 2005). Also, recent work using
either mice tolerized to CSP (Kumar et al., 2006) or transgenic
P. berghei sporozoites expressing P. falciparum CSP (Gruner
et al., 2007) showed that sterile protection was still obtained
with attenuated sporozoite immunizations, despite the absenceell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc. 209
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ReviewFigure 1. The Sporozoite Journey to the Hepatocyte and Subsequent Liver Stage Development: Parasite/Host Interactions
The infectious sporozoite is deposited into the skin and subsequently enters the bloodstream through a capillary endothelial cell (CE). A number of sporozoites
also enter draining lymph nodes and can partially develop within the lymphoid endothelium (LE). Once in the liver sinusoid, sporozoites glide along the fenestrated
endothelia (SE) and cross the sinusoidal cell barrier by traversing a resident Kupffer cell (KC). The sporozoite then traverses a number of hepatocytes before
invading a hepatocyte with the formation of a parasitophorous vacuole membrane (PVM). Massive replication and growth lead to the formation of erythro-
cyte-infectious merozoites that enter the sinusoid packaged in extrusomes/merosomes and are subsequently released in the pulmonary bloodstream. The par-
asite and host proteins known to be involved in the individual steps of this cascade are listed under the appropriate location, and a timeline for the whole process
for rodent parasites and human parasites (postinfection, PI) is depicted at the base of the figure. Those proteins not referred to in the text are apical membrane
antigen-1 (AMA1) and thrombospondin-related sporozoite protein (TRSP).of immune responses specific to CSP. Stimulated by the subop-
timal results obtained with recombinant malaria vaccines, the
live attenuated vaccine approach experienced a revival. There
are currently efforts underway led by Sanaria Incorporated
(http://www.sanaria.com) to produce a live attenuated sporozo-
ite vaccine in mosquitoes and to solve the technical problems
associated with irradiation, large-scale production, purification,
and preservation of sporozoites. Furthermore, genetically atten-
uated parasites (GAPs) have been created that circumvent the
need for irradiation. Mining of the sporozoite transcriptome has al-
lowed the discovery of genes whose protein products are essen-
tial for liver stage development. Deletion of these genes caused
the early cessation of liver stage development and prevented
the onset of blood stage infection (reviewed in Mikolajczak et al.,
2007a). Whenmice were inoculated with theseknockout sporozo-
ites, they were subsequently completely protected against wild-
type sporozoite infection. P. falciparum GAPs are being con-
structed and could be used as a whole-organism malaria vaccine.
The efforts to create a protective GAP have been facilitated
through support from the Bill & Melinda Gates Foundation-spon-
sored Grand Challenges in Global Health program, whose long
term goals are to improve health in the developing world.210 Cell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc.Here, we discuss the most recent data that elucidate the cell
and molecular biology of the parasites on the way from inocula-
tion at the site of a mosquito bite, through their development in
the liver and into the blood stream. We will also highlight areas
where our current understanding of this complex journey is
inadequate.
The Sporozoite Journey from the Skin to the Liver
When a female Anopheles mosquito takes a blood meal, its pro-
boscis probes into the host’s skin. In doing so, saliva is depos-
ited to prevent the blood from coagulating (reviewed in Ribeiro
and Francischetti, 2003). Sporozoites move with gliding motility
from the salivary gland cavities into the salivary ducts and are
ejected within the skin of the host (Frischknecht et al., 2004; Van-
derberg and Frevert, 2004). A few hundred sporozoites can be
deposited into the skin of a mouse by a single mosquito during
a blood meal (Jin et al., 2007). Shortly after their intradermal
deposition, sporozoites start to glide in a fashion and speed
comparable to that seen in vitro (Amino et al., 2006). The
in vivo gliding motility of sporozoites appears random and
follows a corkscrew movement pattern. Quantitative real-time
imaging studies have shown that most sporozoites move by
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where they then breach the endothelial barrier to enter the blood
circulation (Amino et al., 2007; Vanderberg and Frevert, 2004).
Sporozoites can also enter a lymphatic vessel and seem to
then passively reach the draining lymph node of the injection
site, where some of them can partially develop into exoerythro-
cytic stages (Amino et al., 2006). The ability of sporozoites to
glide, as well as to traverse through and invade cells has been
attributed to a number of membrane anchored and secreted pro-
teins. One of these is the thrombospondin-related anonymous
protein (TRAP), a micronemal protein that mediates gliding mo-
tility and invasion both in the mosquito vector salivary gland
and in the mammalian host (Kappe et al., 1999; Sultan et al.,
1997). Moreover, as well as invading cells, the sporozoite has
the ability to traverse through host cells by membrane disruption,
allowing for movement in and out of cells (Mota et al., 2002,
2001; Vanderberg and Stewart, 1990). Traversal, unlike invasion,
does not lead to the production of a PV, within which the devel-
oping parasite grows. Initially, two molecules were identified that
have a role in host cell traversal, named SPECT1 (sporozoite mi-
croneme protein essential for cell traversal 1) and SPECT2 (Ish-
ino et al., 2005a, 2004). The SPECT proteins are secreted by
micronemes. SPECT1 has no similarity to any known proteins,
while SPECT2 (also known as PPLP1) contains a membrane at-
tack complex/perforin-related domain (Kaiser et al., 2004a), sug-
gesting that it might insert into membranes. Mutant sporozoites
lacking either SPECT1 or SPECT2 show in vitro gliding motility
but are unable to traverse through host cells in vitro. Liver infec-
tion rates in vivo were greatly reduced, suggesting that host cell
traversal is needed so sporozoites can cross the sinusoidal cell
layer, likely through the resident macrophage known as the
Kupffer cell (reviewed in Frevert et al., 2006). Since the spectmu-
tant sporozoites showed in vitro gliding motility but no cell tra-
versal activity, it was not clear if in vivo gliding motility or host
cell traversal were necessary for sporozoite traversal to the
blood stream from the skin (Ishino et al., 2005a, 2004). Recently,
though, it has been shown that in vivo host cell traversal is impor-
tant for sporozoite progression through the dermis but not to en-
ter the circulatory system (Amino et al., 2008). In this study,
in vivo imaging of P. berghei spect1 and spect2 parasites ex-
pressing green fluorescent protein (GFP) was accomplished in
the skin of a mouse ear. More than 90% of the mutant sporozo-
ites were immotile in the skin after mosquito deposition. Further-
more, mutant sporozoites were found associated with phago-
cytes and dermal fibroblasts. Despite the apparent lack of cell
traversal, a number of spect knockout parasites were able to
breach the endothelial barrier to reach the blood stream. The au-
thors suggested that cell traversal is important for the passage of
the sporozoite through the dermis but not for breaching endothe-
lial barriers. In addition to SPECT1 and SPECT2, a number of
other proteins have a role in sporozoite cell traversal capacity
prior to hepatocyte infection, including a second TRAP family
member, TLP (TRAP-like protein) (Moreira et al., 2008), a sporo-
zoite-secreted phospholipase (Bhanot et al., 2005), and CelTOS
(cell traversal protein for ookinete and sporozoite) (Kariu et al.,
2006). It is important to note that most of the studies conducted
on sporozoite motility, host cell traversal, and host cell invasion
have been carried out with P. berghei. This parasite is able to in-
vade and grow in a number of host cell types, and it is currentlyCnot known if this phenomenon exists in all Plasmodium species.
Therefore, since the body of evidence for sporozoite cell tra-
versal and invasion has been obtained using P. berghei, inter-
species in vivo imaging studies are needed to reveal possible dif-
ferences in the behavior of malaria parasite sporozoites and their
interaction in the skin prior to their one-way journey to the liver.
Sporozoite Infection of the Liver: Traversal Versus
Invasion
Once the infectious sporozoite enters the bloodstream, it homes
to the liver. How does the sporozoite sense where it is in the host,
and what mechanisms enable it to recognize when it has entered
the liver sinusoid—the route it must take to ultimately gain ac-
cess to its place of further development, a single hepatocyte?
The liver sinusoid is a unique type of blood vessel with a fenes-
trated endothelium through which the oxygen-rich blood from
the hepatic artery and the nutrient-rich blood from the portal
vein flows. A family of liver-specific highly sulfated heparan sul-
fate proteoglycans (HSPGs) is hypothesized to protrude from the
extracellular matrix in the space of Disse (which separates the
endothelial cells from the hepatocytes) through the fenestration
into the sinusoid (reviewed in Frevert, 2004). The HSPGs are pro-
duced by stellate cells within the space of Disse. In addition to
endothelial cells, the sinusoidal cell layer also contains Kupffer
cells—resident liver macrophages that can take up and destroy
foreign material such as bacteria, thereby preventing such mate-
rial from entering the body. An elegant study using intravital im-
aging has shown the movement of sporozoites in the liver (Fre-
vert et al., 2005). The sporozoites used in the study expressed
fluorescent proteins under the control of the CSP promoter,
which is highly expressed at this stage of the parasite life cycle.
In combination with mice expressing fluorescent proteins in si-
nusoidal endothelial cells and Kupffer cells, the authors were
able to visualize sporozoite behavior in the liver sinusoid. Once
they have reached the liver, the sporozoites glide freely for
a number of minutes along the sinusoidal epithelium, a process
that can occur both with and against the flow of blood. It appears
that sporozoites then invade Kupffer cells, traverse them, and
cross into the space of Disse. Once inside the liver
parenchyma, sporozoites continue to traverse through several
hepatocytes. The sporozoite eventually invades a final hepato-
cyte, with formation of a PV, and begins liver stage growth.
To assess the requirement for Kupffer cells in sporozoite liver
infection, the liver infection rate of P. yoelii rodent malaria in ho-
mozygous op/op mice, which have 77% fewer Kupffer cells than
their wild-type littermates, was studied. Liver infection rates
were decreased by 84% in the op/op mice, which indicates
the importance of the Kupffer cell as the portal through which
the sporozoite travels on its way to the liver (Baer et al.,
2007b). Surprisingly, treatment of mice with liposome-encapsu-
lated clodronate, which destroys Kupffer cells (and other phago-
cytic cells) increased sporozoite liver infection up to 15-fold.
However, further analysis using electron microscopy showed
that clodronate treatment had caused the formation of gaps in
the liver sinusoid, possibly allowing sporozoites direct access
to the hepatocytes (Baer et al., 2007b). The fact that sporozoites
enter the liver through a resident macrophage raises an obvious
question. Why is the sporozoite not eliminated by the liver’s pri-
mary defense mechanism to foreign attack? It turns out that theell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc. 211
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necessary for Kupffer cells to destroy sporozoites (Usynin
et al., 2007). CSP is highly expressed by sporozoites, and both
sporozoites and CSP alone were able to induce the generation
of cyclic AMP (cAMP) in Kupffer cells. CSP stimulates adenylyl
cyclase (AC), which causes an upregulation of cAMP activity,
which then inhibits the assembly of the NADPH oxidase, thus
blocking the generation of reactive oxygen species—a potent
macrophage defense mechanism. The ability of sporozoites to
induce cAMP was mediated by both HSPGs and the low-density
lipoprotein receptor-related protein LRP-1, both of which are
found to be highly expressed by Kupffer cells (Usynin et al.,
2007). A further study using P. yoelii sporozoites has also shown
that merely sporozoite contact with Kupffer cells elevates cAMP
levels and prevents the respiratory burst (Klotz and Frevert,
2008). In this case, Kupffer cell invasion was not a prerequisite
and the Kupffer cells exposed to sporozoites exhibited signs of
apoptosis (Klotz and Frevert, 2008). The above data suggest
that Plasmodium sporozoites can manipulate macrophage func-
tion to their own advantage.
Once a sporozoite has traversed through a Kupffer cell, it then
traverses through a number of hepatocytes before finally taking
up residence. Traversal damage and subsequent necrotic hepa-
tocyte death has been confirmed in liver sections, which re-
vealed clusters of necrotic hepatocytes adjacent to structurally
intact, sporozoite-infected hepatocytes (Frevert et al., 2005).
While some hepatocytes die after sporozoite traversal, others
are able to repair the damage to their plasma membrane (Mota
et al., 2001). It is not currently understood exactly why sporozo-
ites traverse through a number of hepatocytes before finally in-
vading and residing in the hepatocyte in which they will replicate.
It appears that traversal through hepatocytes is essential for the
induction of apical-regulated exocytosis (Mota et al., 2002),
a process which is necessary for cell invasion (Bannister and
Mitchell, 1989) but the exact mechanism by which this occurs
is not known. Apical-regulated exocytosis has been shown in
sporozoites by measuring release of TRAP at the apical end of
the parasite and its subsequent release into the medium. In-
creasing the cytosolic cAMP levels in Plasmodium sporozoites
with the addition of the cell permeable cAMP analog 8 bromo
(8Br)-cAMP induces exocytosis in vitro, as measured by an in-
crease in the accumulation of extracellular TRAP at the apical
end of sporozoites (Ono et al., 2008). Since cAMP is synthesized
by AC and the incubation of sporozoites with the AC inhibitor
MDL-12.330A prevented sporozoite exocytosis, it is presumed
that the synthesis of cAMP by AC increases sporozoite exocyto-
sis. Indeed, the treatment of P. yoelii sporozoites with 8Br-cAMP
decreased their ability to traverse through monolayers of the
hepatoma cell line Hepa 1-6 and increased their ability to invade
the cells (Ono et al., 2008). The major downstream target of
cAMP is protein kinase A (PKA) and inhibition of PKA activity
by H89 reduced sporozoite exocytosis. Searching the malaria
genome for AC genes revealed the presence of two different
genes—ACa and ACb. Based on microarray analysis, P. falcipa-
rum ACa is expressed in sporozoites (Le Roch et al., 2003) and
the deletion of P. berghei ACa did not alter parasite growth dur-
ing blood stages or in the mosquito (Ono et al., 2008). However,
activation of apical exocytosis in the aca sporozoite was greatly
reduced and resulted in a defective invasion of Hepa1-6 cells212 Cell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc.in vitro and a decrease in liver parasite load 40 hr after spo-
rozoite infection of mice in vivo.
Sporozoite traversal through hepatocytes induces the secre-
tion of host hepatocyte growth factor (HGF), which was reported
to render hepatocytes susceptible to infection (Carrolo et al.,
2003). Studies with P. berghei showed that the removal of HGF
with antibodies decreased the number of liver stages formed
in vitro after sporozoite infection of the hepatoma cell line
HepG2. The receptor for HGF is the tyrosine kinase MET. Incu-
bation of Hepa1-6 cells with P. berghei sporozoites activated
MET and HepG2 cells expressing a constitutively active MET
were more susceptible to sporozoite infection, suggesting that
the effect of HGF on sporozoite infection was mediated through
MET. HGF/MET signaling induced host cell actin reorganization,
and this was shown to be necessary for early liver stage develop-
ment. In addition, HGF/MET signaling prevents the apoptosis of
parasite-infected cells, thus ensuring successful liver stage rep-
lication (Leiriao et al., 2005). Thus, the host protein HGF, released
upon sporozoite traversal appears to be important for the down-
stream invasion and early liver stage development of the para-
site.
Sporozoite entry into cells (both traversal and invasion) is de-
pendant on micronemes, which secrete proteins necessary for
the parasite to cross the plasma membrane of host cells and
also to form the moving junction when invasion accompanied
with PV membrane (PVM) formation occurs. As has already
been mentioned, SPECT1 and SPECT2 are intimately involved
in host cell traversal. What about sporozoite invasion of hepato-
cytes with the formation of a PVM? Two parasite molecules are
involved in this process —P36 and P52/P36p (Ishino et al.,
2005b; van Dijk et al., 2005), the genes for which are arranged
in tandem within the Plasmodium genome. These two proteins
are members of the 6-cys protein family (Templeton and Kaslow,
1999), and P52/P36p has a putative glycophosphatidylinositol
(GPI)-anchoring domain that allows the attachment of the protein
to the sporozoite membrane via a GPI anchor. Disruption of ei-
ther P52/P36p or P36 in P. berghei gave rise to normal numbers
of sporozoites but the sporozoites, although able to traverse
cells, were defective in the final invasion of hepatocytes (Ishino
et al., 2005b; van Dijk et al., 2005). In P. yoelii, the simultaneous
disruption of both P36 and P52/P36p gave rise to sporozoites
that were completely unable to form a PVM (Labaied et al.,
2007). The result of this dual gene deletion was that the liver
stage of the parasite did not develop and a blood stage infection
did not occur, indicating that P52/P36p and P36 might have
cooperative functions or have functions that are partially redun-
dant. Together, it appears that they have a critical role in a
process that leads to formation of a PVM. However, further stud-
ies are needed to elucidate the molecular mechanisms of PVM
induction. The identification of host cell receptors that bind
P36 and P52/P36p is an important step in this direction but
has yet to be accomplished.
In the process of plasma membrane rupture during cell tra-
versal, cytosolic factors are released into the microenvironment
which activate NF-kB, the main regulator of host inflammatory
responses (Torgler et al., 2008). This activation of NF-kB oc-
curred shortly after cell rupture and led to a reduction of infection
load in a time-dependent manner both in vitro and in vivo. NF-kB
activation was not observed when spect knockout parasites
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were increased by the addition of an NF-kB inhibitor, demon-
strating the importance of its induction in the process of the
host inflammatory response. Furthermore, primary hepatocytes
from mice lacking myeloid differentiation primary response 88
(MyD88), which is an adaptor protein used by Toll-like receptors
to activate NF-kappaB, showed no NF-kB activation upon mem-
brane rupture, suggesting a role of the Toll-like receptor family
sensing cytosolic factors. In fact, the lack of MyD88 significantly
increased infection in vitro and in vivo. Thus, host cell wounding,
although apparently beneficial for the sporozoite to adopt an in-
vasive state, is also likely to limit host cell infection through acti-
vation of the inflammatory response. Intriguingly, pre-erythro-
cytic stages also counter inflammation by inducing the release
of host anti-inflammatory factors. The anti-inflammatory enzyme
heme oxygenase-1 (HO-1) has recently been shown to be upre-
gulated in the liver following both P. berghei and P. yoelii infec-
tion (Epiphanio et al., 2008). Mice expressing an increased
amount of HO-1 by infection with an HO-1-expressing adenovi-
rus developed a more severe parasite liver load after P. berghei
sporozoite infection. Conversely, mice lacking the HO-1 gene
(Hmox1) did not develop blood stage parasitemia after infection
withP. berghei sporozoites. The induction of HO-1 during P. ber-
ghei liver infection protects the infected hepatocytes by control-
ling the inflammatory response, as seen by a dramatic reduction
in inflammatory foci and a decrease in the number of inflamma-
tory cells and cytokines when comparing HO-1 adenovirus-
treated mice with the Hmox1/ mice (Epiphanio et al., 2008).
At present, it is not known how sporozoite infection increases
HO-1 activity, and it will be of interest to determine which para-
site factors play a role in this protective mechanism.
A further host cell protein involved in sporozoite invasion is the
tetraspanin ‘‘cluster of differentiation 81’’ (CD81). This is required
on hepatocytes for P. yoelii sporozoite invasion with PVM forma-
tion (Silvie et al., 2003). P. yoelii sporozoites were unable to infect
CD81-deficient mouse hepatocytes, both in vivo and in vitro, and
antibodies against mouse and human CD81 inhibited the in vitro
hepatic development of P. yoelii and P. falciparum, respectively.
Further study has revealed that cholesterol is involved in the as-
sembly of CD81 microdomains on the cell surface and is neces-
sary for sporozoite infection (Silvie et al., 2006). The cholesterol
necessary for this assembly is likely supplied by the host hepa-
tocyte scavenger receptor BI (SR-BI)—a receptor that mediates
the selective uptake of cholesteryl esters from both high- and
low-density lipoprotein. Two groups have recently shown that
SR-BI plays a critical role in Plasmodium hepatocyte infection
(Rodrigues et al., 2008; Yalaoui et al., 2008a). Primary hepato-
cytes isolated from SR-BI transgenic mice had an enhanced per-
missiveness to both P. yoelii and P. berghei sporozoite infection,
whereas hepatocytes isolated from SR-BI/ mice and hypo-
morphic-SR-BI mice (which express approximately 10% of nor-
mal SR-BI levels) were less permissive to infection (Yalaoui et al.,
2008a). Similarly, reducing SR-BI expression with siRNA in
HUH7 hepatoma cells led to a significant reduction in P. berghei
infection rates, and in vivo, the use of SR-BI siRNAs significantly
reduced liver infection in P. berghei sporozoite-infected mice
(Rodrigues et al., 2008). Unexpectedly however, Rodrigues
et al. did not see a significant effect on liver stage burden in
SR-BI/ mice when compared to wild-type mice. Interestingly,the authors observed a dramatic increase in HO-1 levels in
SR-BI/ mice. This observation was used as evidence to ex-
plain the apparently similar susceptibility in WT and SR-BI/
mice inoculated with P. berghei parasites. The authors con-
cluded that the dramatic increase in HO-1 levels in SR-BI/
mice counteracts the expected decrease in liver stage burden
and also showed that the hypomorphic-SR-BI mice (which
have levels of HO-1 similar to WT mice) indeed had the expected
decrease in levels of liver stage burden (Rodrigues et al., 2008).
In addition, there appears to be a strong connection between
SR-BI and CD81. Yalaoui et al. demonstrated that SR-BI defi-
ciency caused a decreased expression of CD81 on the cell sur-
face and the authors concluded that SR-BI functions to provide
the necessary cholesterol for tetraspanin microdomain assem-
bly (Yalaoui et al., 2008a). Using a similar tetraspanin, CD9, to
produce CD9/CD81 chimeras, it has been shown that a 21 amino
acid stretch of CD81 located in a domain structurally conserved
in the large extracellular loop of all tetraspanins is sufficient in an
otherwise CD9 background to confer susceptibility to in vitro
P. yoelii infection (Yalaoui et al., 2008b). Intriguingly, P. berghei
does not depend on CD81 for invasion of human hepatoma
cell lines and can invade mouse hepatoma cell lines in a CD81-
dependent and -independent manner (Silvie et al., 2007), further
evidence for the promiscuous nature of this rodent parasite.
As already discussed, sporozoites traverse cells, but for repli-
cation to take place the sporozoite must invade a cell and form
a PV, which separates it from the host cell cytoplasm and allows
its development into infectious merozoites. What parasite and
host factors induce the switch from traversal to productive inva-
sion? Recent data indicate that the sulfation levels on HSPGs act
as a cue that guides the sporozoite to choose its infection mode
(Coppi et al., 2007). In 1993, it was discovered that CSP recog-
nizes and binds HSPG expressed on the surface of hepatocytes
and the hepatoma cell line HepG2 (Frevert et al., 1993). The bind-
ing was abolished by heparinase treatment—an enzyme that
removes highly sulfated heparan sulfate glycosaminoglycan
chains from HSPGs, indicating that the recognition was via the
glycosaminoglycan chains of the HSPGs. It was later discovered
that the degree of sulfation of the glycosaminoglycan chains at
both the N and O positions of the HSPGs were important for
the binding of CSP (Pinzon-Ortiz et al., 2001; Ying et al., 1997)
and that highly sulfated heparins (naturally occurring HSPGs)
had an enhanced ability to competitively inhibit the attachment
of sporozoites to HepG2 cells. Further studies analyzing the
overall extent of sulfation of heparan sulfate on a variety of cell
types demonstrated that the hepatoma cell line Hepa 1-6 had
the highest levels, when compared to either a mouse dermal
fibroblast cell line or an endothelial cell line, adding further evi-
dence that the unique level of sulfation of liver HSPGs triggers
the attachment of the migrating sporozoite (Coppi et al., 2007).
Interestingly, the change in sporozoite behavior —from traversal
to invasion—was directly related to the cleavage of CSP (Coppi
et al., 2007). This cleavage is mediated by a member of the pa-
pain family of cysteine proteases of sporozoite origin (Coppi
et al., 2005). Treatment of sporozoites with E-64, a specific inhib-
itor of cysteine proteases, prior to an in vitro infection of hepa-
toma cells or the treatment of mice with E-64 prior to an in vivo
sporozoite inoculation, was able to completely inhibit sporozoite
infectivity (Coppi et al., 2005), demonstrating the requirement forCell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc. 213
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sporozoites with soluble heparin also triggered the invasion
response, allowing them to invade typically nonpermissive cells
such as dermal fibroblasts and endothelial cells as well as Hepa
1-6 cells that had been treated with the sulfation inhibitor chlo-
rate (Coppi et al., 2007). Undoubtedly, the triggering of CSP
cleavage is associated with signaling events that enable the on-
set of sporozoite invasion. Such cascades are typically mediated
by protein kinases, and the broad range protein kinase inhibitor,
staurosporine, is able to inhibit sporozoite invasion (Mota et al.,
2002). Plasmodium has a family of calcium-dependent proteins
kinases (CDPKs) (Ward et al., 2004), and calcium signaling plays
a central role in the regulation of sporozoite cell traversal and in-
vasion (Mota et al., 2002). Although no selective Plasmodium
CDPK inhibitors have been discovered, the antagonist W-7 is
known to inhibit plant CDPKs, and KN-93 inhibits structurally
similar animal calmodulin-dependent protein kinases.Like stauro-
sporine, these inhibitors were also able to decrease sporozoite
invasion and CSP processing (Coppi et al., 2007), suggesting
a role for CDPKs in the signaling cascade involved in sporozoite
invasion. The transcription level of a newly described member of
the Plasmodium CDPK-family, CDPK-6, was found to be high in
P. falciparum sporozoites (Le Roch et al., 2003). CDPK-6 was
subsequently knocked out in P. berghei (Coppi et al., 2007),
and cdpk-6 sporozoites showed a marked decrease in invasive
capabilities and a severe decrease in CSP cleavage when com-
pared to wild-type sporozoites. Furthermore, incubation of the
CDPK-6 parasites with heparin did not increase their ability to
invade Hepa 1-6 cells (Coppi et al., 2007). Taken together, these
data suggest that CDPK-6 is involved in the signaling cascade
brought about by the binding of CSP to the highly sulfated hepa-
tocyte HSPGs that leads to the induction of the invasive pheno-
type of sporozoites and the subsequent establishment of the PV.
It is tempting to speculate that CDPK-6 signaling leads to release
of P36 and P52/P36p, the aforementioned proteins that are
necessary for PV formation.
Liver Stage Growth and Merozoite Egress
Due to their low number and inaccessibility, Plasmodium liver
stages are the most difficult life cycle stage of the parasite to
study. Thus, little is known about the intracellular existence of
this rare and elusive stage of the parasite. The liver stage exhibits
discrete developmental stages. Initially, after invasion with the
consequence of PV formation and establishment of the parasite
inside a PVM, the invasive sporozoite dedifferentiates and de-
velops into a liver trophozoite. Surprisingly, this early transforma-
tion can take place extracellularly and only requires serum and
a temperature increase to 37C, suggesting that the host cell fac-
tors are not required for this transformation (Kaiser et al., 2003).
Beyond the trophozoite stage, liver stage growth through schi-
zogony is intense and undoubtedly requires nutrients from the
host cell. It also requires extensive manipulation of the hepato-
cyte since the intracellular parasite is able to grow and increase
its volume dramatically without annihilating the host cell—an ex-
ceptional achievement. Cell stress is typically known to trigger
programmed cell death (apoptosis), and examination of the hep-
atoma cell line HepG2 infected with P. berghei showed a lack of
apoptotic signaling (van de Sand et al., 2005). Indeed, parasite
infection confers resistance to apoptosis of the host cell. To214 Cell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Incshow the physiological relevance of this, mice were infected
with high numbers of P. berghei sporozoites and then treated
with tumor necrosis factor (TNF)-a and d-glucosamine to induce
liver apoptosis. Liver sections of these mice, stained for
degraded DNA, confirmed that infected cells containing viable
parasites were protected from programmed cell death.
In addition to the activities already mentioned for CSP, this
multifunctional protein also promotes liver stage development.
CSP contains PEXEL (Plasmodium export element) motifs that
export parasite proteins to the host cell cytoplasm. These motifs
are functional in CSP, and their deletion fromP. bergheiCSP pre-
vented transport of the protein into the hepatocyte cytoplasm
and caused a decrease in liver stage development (Singh
et al., 2007). Interestingly, CSP also contains a functional nuclear
localization signal (NLS) that binds primarily to host importin-a3
and deletion of the NLS diminished liver stage growth. Further-
more, the NLS domain of CSP competes with NF-kB for binding
to importin-a3. Thus, it is believed to play a role in inhibiting the
host inflammatory responses necessary to prevent liver stage
development (Singh et al., 2007). It is thus obvious that CSP
plays a major role in ensuring the sporozoite reaches the liver
and initiates liver stage development.
The hepatocyte is a major synthesizer of lipids and purines as
well as a store for glycogen and thus should be able to provide
the developing liver stage with the nutrients it requires for the
generation of the thousands of red blood cell-infectious merozo-
ites that are released into the circulation. Recent studies of the
liver stage PVM have shown that it is associated with the host
cell endoplasmic reticulum but not with host cell mitochondria
or lysosomes (Bano et al., 2007). The PVM has also been shown
to contain pores that restrict the passage of solutes to less than
855 Daltons in size (Bano et al., 2007). Nevertheless, the liver
stage PV appears to be an active and highly permeable compart-
ment that ensures the continued supply of nutrients to support
parasite growth. It is currently not clear how larger nutrients
cross the PVM but parasite proteins expressed on the surface
of the PVM are definitely involved in liver stage growth progres-
sion. Advances in understanding the liver stage PVM came ini-
tially from studies that aimed to elucidate why sporozoites
from the mosquito salivary glands but not midgut oocysts are
highly infectious for the liver (Matuschewski et al., 2002). Using
suppression subtractive hybridization, a number of genes that
were upregulated in infectious sporozoites (UIS genes) were iso-
lated. Two of these genes, UIS3 and UIS4, when independently
deleted from P. berghei or P. yoelii, caused liver stage growth
arrest and prevented the subsequent blood stage infection (Mu-
eller et al., 2005a, 2005b; Tarun et al., 2007). UIS3 and UIS4 are
initially localized in secretory organelles of infectious sporozoites
and, after invasion, localize to the PVM of liver stages where they
are continuously expressed up to late schizont development
(Kaiser et al., 2004b; Mikolajczak et al., 2007b; Mueller et al.,
2005a). It has recently been shown, using a yeast two-hybrid
screen that UIS3 interacts with hepatocyte liver fatty acid binding
protein (L-FABP) (Mikolajczak et al., 2007b). As its name
suggests, L-FABP is a hepatocyte-specific fatty acid carrier
that enables fatty acids to be shuttled through the cytoplasm.
Using L-FABP specific siRNA to downregulate its expression in
the hepatoma cell line HUH7, significantly decreased the growth
of P. berghei liver stages when compared to cells transfected.
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increased by transfection with a plasmid carrying the L-FABP
cDNA into HUH7 cells, P. berghei growth was increased. Impor-
tantly, P. falciparum UIS3 has recently been crystallized
in association with the lipid phosphatidylethanolamine and
directly interacts with human L-FABP (Sharma et al., 2008). Inter-
estingly, there is a link between L-FABP and SR-BI. As men-
tioned earlier, SR-BI plays an important role in sporozoite infec-
tion of hepatocytes. In addition, SR-BI appears to be also
involved in liver stage development. In turns out that L-FABP
levels were reduced in SR-BI/ hepatocytes and increased in
transgenic SR-BI hepatocytes when compared to WT (Yalaoui
et al., 2008a). Schizont size at 48 hr post P. yoelii sporozoite
infection of primary hepatocytes was about 27-fold more volumi-
nous in SR-BI transgenic hepatocytes when compared to SR-
BI/ hepatocytes (Yalaoui et al., 2008a). Therefore, the growth
supportive effect of SR-BI might at least in part be mediated
by L-FABP. Together, these data support the scenario that
SR-BI can supply the necessary exogenous lipids for liver stage
growth, L-FABP transports these lipids to the PVM and interacts
with UIS3 to exchange the lipids, which are then, by a yet to be
defined mechanism, utilized by the developing liver stage.
An additional gene that is expressed exclusively in sporozoites
and liver stages was shown to be essential for liver stage devel-
opment. The gene product has been named both sporozoite
asparagine-rich protein (SAP1) (Aly et al., 2008) and also sporo-
zoite and liver stage asparagine-rich protein (SLARP) (Silvie
et al., 2008). Targeted deletion of SAP1 in P. yoelii and of SLARP
in P. berghei did not have any effect on parasite blood stage rep-
lication or mosquito stage development. However, even though
both sap1 and slarp sporozoites were able to invade hepato-
cytes, they were unable to initiate liver stage development and
consequently were unable to generate a blood stage infection.
Strikingly, the absence of SAP1/SLARP in P. yoelii/P. berghei re-
spectively abolished the expression of a number of essential UIS
genes, including UIS3 and UIS4, but genes encoding proteins
such as CSP and TRAP were mostly unaffected. Protein localiza-
tion data between the two reports were conflicting. Using spe-
cific SAP1 antisera that did not react with sap1 parasites, Aly
et al. localized SAP1 to the cell interior but not the nucleus of spo-
rozoites (Aly et al., 2008). Conversely, Silvie et al. attached a fluo-
rescent tag to SLARP and visualized a nuclear staining (Silvie
et al., 2008). Since the methods used to localize the protein
were different, it is not presently clear where SAP1/SLARP
resides. However, this information is important because SAP1/
SLARP could act by increasing the transcription of UIS genes
(nuclear localization) or by stabilizing UIS mRNAs (cytoplasmic
localization).
Although liver stages are notoriously difficult to study, the gen-
eration of recombinant P. berghei (Franke-Fayard et al., 2004)
and P. yoelii (Tarun et al., 2006) parasites, which actively express
green fluorescent protein (GFP), have allowed intravital imaging
of liver stages and also their isolation by fluorescence-activated
cell sorting (FACS) (Tarun et al., 2006). Using FACS to isolate liver
stages from GFP-expressingP. yoelii parasites has allowed a de-
tailed analysis of the transcriptome and generation of a partial
proteome (Tarun et al., 2008). This effort has enabled a detailed
analysis of the genes that are upregulated in liver stage develop-
ment when compared to other life cycle stages. One of the find-Cings from this work was that genes encoding enzymes of the type
II fatty acid synthesis (FAS II) pathway were highly upregulated in
late liver stage development. Furthermore, inhibitors of this path-
way, which is located in the parasite apicoplast (Ralph et al.,
2004), were able to reduce liver stage development in vitro.
This is exciting, as it raises the possibility that inhibition of the
FAS II pathway, which is not present in the human host, could
prevent liver stage development. Clearly, our ability to mine the
liver stage gene transcription and protein expression profiles
has great potential for the discovery of the molecules involved
in liver stage development.
Intravital microscopy of GFP-expressing P. yoelii and P. ber-
ghei parasites has also allowed a detailed description of how
exoerythrocytic merozoites egress from their host hepatocyte
and enter the bloodstream. Parasites induce the death and de-
tachment of their host hepatocyte, and this is followed by the
budding of merozoite-filled vesicles (extrusomes/merosomes)
into the sinusoidal lumen (Sturm et al., 2006; Tarun et al.,
2006). The extrusomes/merosomes are surrounded by host
cell membrane and do not expose the classical apoptotic sig-
nal—phosphatidylserine—at their surface, suggesting that the
infected hepatocyte did not undergo apoptosis before extru-
some/merosome release (Baer et al., 2007a; Sturm et al.,
2006). In vivo studies on GFP-expressing P. yoelii liver stages
have also shown that the majority of extrusomes/merosomes
exit the liver intact and adapt a relatively uniform size, in which
100–200 merozoites reside (Baer et al., 2007a). Extrusomes/
merosomes then survive the subsequent passage through the
right heart and accumulate in the lungs. Ex vivo analysis showed
that extrusomes/merosomes break up inside pulmonary capil-
laries with the subsequent liberation of merozoites into the
bloodstream. Release of merozoites in host cell membrane-
wrapped packages might be an additional mechanism by which
the parasite evades attack by macrophages in the liver.
Conclusions
This Review has concentrated on recent efforts to characterize
the parasite and host molecules that ensure the Plasmodium
sporozoite reaches the liver and subsequently develops into
red blood cell-infectious merozoites (Figure 1). However, current
experimental data provide incomplete information, and some-
times differences in data on a number of key issues and these
discrepancies have yet to be resolved. For one, little is known
about how the proteins that are released from the micronemes
can have such distinct functions in motility, traversal, invasion,
and PVM remodeling. Are there subpopulations of micronemes
that discharge their contents at different times? In addition—
although involved in cell traversal and invasion—what are
SPECT1, SPECT2, CelTOS, P36, and P52/P36p actually doing?
It is still up for debate whether the sporozoite, as has been sug-
gested (Mota et al., 2001, 2002), has an absolute need to tra-
verse through cells in order for its ultimate invasion of a hepato-
cyte. Deletion of SPECT genes gave rise to sporozoites that are
unable to traverse through cells in vitro but can still cause an
in vivo infection (Amino et al., 2008; Ishino et al., 2004, 2005a).
How is this possible? Perhaps sporozoites are able to glide be-
tween cells and finally reach the hepatocyte, but this seems un-
likely. It has also been suggested that the highly sulfated HSPGs
found in the liver promote a switch from traversal to invasion, andell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc. 215
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before reaching its place of further development (Coppi et al.,
2007). Further evidence suggests that traversal is ‘‘turned on’’
for the journey to the liver and then ‘‘turned off’’ before invasion
of the final hepatocyte (Amino et al., 2008). Gene deletions of
molecules involved in these processes only add to the confusion
as in vivo they all appear to diminish passage to the liver but do
not prevent it— suggesting a degree of functional redundancy.
The passage of sporozoites through the Kupffer cell is also con-
tentious. Removal of Kupffer cells still allows liver stage infection,
yet this could be due to ‘‘holes’’ appearing in the endothelial layer
of the sinusoid (Baer et al., 2007b), thus allowing a direct passage
for the sporozoite to a hepatocyte. Experimental evidence sug-
gests a direct role of CSP in preventing Kupffer cells from induc-
ing proinflammatory responses (Usynin et al., 2007), but does
this mean that the sporozoitemust enter this cell in order to reach
the liver? Could the sporozoite simply pass through an endothe-
lial cell as it appears to do to enter skin capillaries? Finally, spo-
rozoites require hepatocyte surface molecules such as CD81 to
enter hepatocytes (Silvie et al., 2003) but the receptor(s) on the
parasite that interact with host cell ligands remain elusive.
In contrast to the apparent redundancy of molecules involved
in the sporozoite invasion of the liver, a number of gene deletions
completely prevent early liver stage development. Nevertheless,
UIS3 is the only liver stage protein currently known to interact di-
rectly with a host cell protein (Mikolajczak et al., 2007b; Sharma
et al., 2008), presumably to funnel nutrients into the developing
liver stage. What other proteins are involved in assuring the liver
stage grows and controls the host cell? What is the function of
UIS4, and what other proteins are expressed on the liver stage
PVM? Late liver stage development is still a black box; the par-
asite is undergoing colossal growth and replication, and yet we
know almost nothing about the molecular processes involved.
Certainly, recent transcriptome and proteome data on late liver
stages have unearthed candidate metabolic pathways, including
fatty acid synthesis, that are upregulated during this major ex-
pansion, but whether these pathways are necessary for parasite
development has yet to be determined.
The availability of new tools to study liver stage development
(both in vitro and in vivo) will hopefully soon herald an enhanced
understanding of this elusive life cycle stage. Ultimately, prevent-
ing liver stage development will prevent malaria, and new meth-
odologies for liver stage intervention (both drugs and vaccines)
will emanate from continued research in this field.
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